Robert Nelsen - Jun 14, 2023 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
Director, 10%+ Owner
Signature
/s/ Gabriela Morales-Rivera, attorney-in-fact
Stock symbol
PRME
Transactions as of
Jun 14, 2023
Transactions value $
$0
Form type
4
Date filed
6/16/2023, 05:49 PM
Previous filing
Jun 12, 2023
Next filing
Jun 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +39.1K $0.00 39.1K Jun 14, 2023 Class A Common Stock 39.1K $14.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in full upon the earlier of (i) June 14, 2024 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.